Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ventas ( (VTR) ) just unveiled an announcement.
On February 9, 2026, Ventas, Inc. amended its at-the-market equity offering program, increasing the aggregate gross sales price of common stock available for issuance to $2.5 billion, excluding shares previously sold under the arrangement. The amendment also added M&T Securities, Inc. as an additional sales agent, while leaving the material terms and conditions of the sales agreement otherwise unchanged.
The updated capacity under the ATM program, supported by a syndicate of major broker-dealers and forward purchasers, enhances Ventas’s flexibility to raise equity capital as needed through sales of common stock and related forward transactions. This expanded funding avenue may support the company’s ability to finance investments, manage its balance sheet and pursue strategic initiatives in the healthcare real estate market without committing to a single large, upfront equity issuance.
The most recent analyst rating on (VTR) stock is a Buy with a $91.00 price target. To see the full list of analyst forecasts on Ventas stock, see the VTR Stock Forecast page.
Spark’s Take on VTR Stock
According to Spark, TipRanks’ AI Analyst, VTR is a Outperform.
Overall score reflects strong cash-flow momentum and constructive 2026 guidance (especially SHOP growth and occupancy gains), supported by bullish price trend signals. The main constraints are elevated valuation (very high P/E), leverage/low ROE typical of the model, and execution risks from equity-funded acquisitions and higher refinancing costs.
To see Spark’s full report on VTR stock, click here.
More about Ventas
Ventas, Inc. is a real estate investment trust focused on healthcare and senior living properties, primarily owning and managing a portfolio of seniors housing communities, medical office buildings and other healthcare-related real estate in the U.S. and select international markets. The company provides capital and real estate solutions to healthcare operators and aims to benefit from long-term demographic and healthcare demand trends.
Average Trading Volume: 2,933,417
Technical Sentiment Signal: Buy
Current Market Cap: $40.15B
Find detailed analytics on VTR stock on TipRanks’ Stock Analysis page.